Connor, Clark & Lunn Investment Management Ltd. - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 143 filers reported holding SANGAMO THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,098,667
-62.9%
349,894
-42.2%
0.01%
-68.4%
Q3 2022$2,964,000
+85.4%
604,938
+56.7%
0.02%
+90.0%
Q2 2022$1,599,000
+140.5%
386,126
+237.5%
0.01%
+233.3%
Q1 2022$665,000
-36.3%
114,414
-17.8%
0.00%
-40.0%
Q4 2021$1,044,000
-60.0%
139,159
-52.0%
0.01%
-64.3%
Q3 2021$2,613,000
+18.1%
290,028
+56.8%
0.01%
+27.3%
Q2 2021$2,213,000
+95.3%
184,912
+104.5%
0.01%
+83.3%
Q1 2021$1,133,000
-47.1%
90,406
-34.1%
0.01%
-53.8%
Q4 2020$2,142,000
+1175.0%
137,263
+671.4%
0.01%
+1200.0%
Q3 2020$168,000
-41.9%
17,793
-67.9%
0.00%
-50.0%
Q1 2017$289,000
+66.1%
55,509
-3.0%
0.00%
+100.0%
Q4 2016$174,000
-46.5%
57,209
-18.4%
0.00%
-50.0%
Q3 2016$325,000
-65.7%
70,109
-57.2%
0.00%
-71.4%
Q2 2016$948,000
-45.4%
163,709
-42.9%
0.01%
-46.2%
Q1 2016$1,735,000
-46.8%
286,809
-19.8%
0.01%
-51.9%
Q4 2015$3,264,000
+104.6%
357,509
+26.4%
0.03%
+107.7%
Q3 2015$1,595,000
+38.8%
282,884
+173.1%
0.01%
+30.0%
Q2 2015$1,149,000
-42.1%
103,572
-18.2%
0.01%
-41.2%
Q1 2015$1,986,000
-4.8%
126,672
-7.7%
0.02%0.0%
Q4 2014$2,086,000
+298.9%
137,172
+182.8%
0.02%
+325.0%
Q3 2014$523,000
-50.9%
48,500
-9.2%
0.00%
-50.0%
Q1 2014$1,066,00053,4000.01%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders